Amneal Pharma has launched its commercial operations in India. To helm its India commercial operations, Amneal has appointed Shyamakant Giri as Managing Director and President, India Business and Emerging Markets. In his new role, he will be responsible for Amneal’s commercial expansion and growth in India, Africa, Gulf, CIS and South Asian markets. Giri has over two decades of experience leading business divisions and strategic operations of leading Indian and multinational organisations, according to a statement from Amneal Pharma.
The statement said that with the commencement of Amneal’s India commercial operations, the company aims to serve the unmet medical needs, and extend its industry-leading reputation for high quality products at affordable prices.
Chirag and Chintu Patel, Co-Chief Executive Officers, Amneal, said in the statement, “…………….. Being a community-oriented firm, we have placed a specific emphasis on innovating products that address the market’s unmet needs. Onboarding an industry veteran like Giri, who shares our vision, will be a major impetus behind Amneal’s growth in India.”
Giri added, “I am honoured to be a part of the Amneal family. A purpose-driven company with a legacy of more than two decades, Amneal has been a rising leader in the US pharmaceutical industry, and now is bringing access to global quality medical solutions in India today. With Amneal’s 20+ year legacy of strong R&D, expansive portfolio and know how, I believe we can deliver substantial value in addressing the country’s medical requirements and offer solutions to numerous health concerns.”